Abstract
α-Iso-cubebene (ICB) is a dibenzocyclooctadiene lignin contained in Schisandra chinensis (SC), a well-known medicinal herb that ameliorates cardiovascular symptoms. Thus, we examined the effect of ICB on vascular smooth muscle cell (VSMC) proliferation, a key feature of diverse vascular diseases. When VSMCs primary cultured from rat thoracic aorta were stimulated with PDGF (1–10 ng/ml), cell proliferation and osteopontin (OPN) expression were concomitantly up-regulated, but these effects were attenuated when cells were treated with MPIIIB10, a neutralizing monoclonal antibody for OPN. In aortic tissues exposed to PDGF, sprouting VSMC numbers increased, which was attenuated in tissues from OPN-deficient mice. Furthermore, VSMC proliferation and OPN expression induced by PDGF were attenuated dose-dependently by ICB (10 or 30 μg/ml). Reporter assays conducted using OPN promoter-luciferase constructs showed that the promoter region 538–234 bp of the transcription start site was responsible for transcriptional activity enhancement by PDGF, which was significantly inhibited by ICB. Putative binding sites for AP-1 and C/EBPβ in the indicated promoter region were suggested by TF Search, and increased binding of AP-1 and C/EBPβ in PDGF-treated VSMCs was demonstrated using a ChIP assay. The increased bindings of AP-1 and C/EBPβ into OPN promoter were attenuated by ICB. Moreover, the PDGF-induced expression of OPN was markedly attenuated in VSMCs transfected with siRNA for AP-1 and C/EBPβ. These results indicate that ICB inhibit VSMC proliferation by inhibiting the AP-1 and C/EBPβ signaling pathways and thus downregulating OPN expression.
Highlights
Vascular smooth muscle cells (VSMCs) are essential regulators of vascular function [1,2]
Increased bindings between activator protein 1 (AP-1) or CCAAT/enhancerbinding protein beta (C/EBPβ) and OPN promoter in Platelet derived growth factor (PDGF)-stimulated cells were demonstrated by a Chromatin immunoprecipitation (ChIP) assay, and these bindings were attenuated by ICB
These results suggested that ICB attenuated PDGF-induced VSMC proliferation by inhibiting the AP-1 and C/EBPβ signaling pathways and down-regulating OPN expression in VSMCs
Summary
Vascular smooth muscle cells (VSMCs) are essential regulators of vascular function [1,2]. OPN was reported to be strongly expressed in a synthetic VSMC phenotype [15], and suggested to be a key factor of the development of vascular remodeling diseases [16,17]. VSMCs exhibit phenotypic changes characterized by loss of contractility, abnormal proliferation, migration, and matrix secretion [10]. This synthetic phenotype of VSMCs plays an active role in the development of several cardiovascular diseases, including vascular remodeling diseases [26,27,28]. We undertook this study to determine the relations between ICB and OPN and PDGF-stimulated VSMC proliferation, and to identify the ICB-targeted transcription factors underlying OPN expression in VSMCs
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.